Ketamine ameliorates severe traumatic event-induced antidepressant-resistant depression in a rat model through ERK activation

Chi Wei Lee, Yi Ju Chen, Han Fang Wu, Yueh Jung Chung, Yi Chao Lee, Cheng Ta Li, Hui Ching Lin

Research output: Contribution to journalArticle

Abstract

Treatment-resistant depression (TRD) is a major public health issue, as it is common for patients with depression to fail to respond to adequate trials of antidepressants. However, a well-established animal model of TRD is still warranted. The present study focused on selective serotonin reuptake inhibitor (SSRI) resistance, and aimed to investigate whether higher levels of traumatic stress caused by greater numbers of foot-shocks may lead to severe depression and to examine the feasibility of this as an animal model of SSRI-resistant depression. To reveal the correlation between traumatic stress and severe depression, rats received 3, 6 and 10 tone (conditioned stimulus, CS)–shock (unconditioned stimulus, US) pairings to mimic mild, moderate, and severe traumatic events, and subsequent depressive-like behaviors and protein immunocontents were analyzed. The antidepressant efficacy was assessed for ketamine and SSRI (i.e., fluoxetine) treatment. We found that only the severe stress group presented depressive-like behaviors. Phosphorylation of extracellular signal-regulated kinases (ERKs) was decreased in the amygdala and prefrontal cortex (PFC). The immunocontents of GluA1 and PSD 95 were increased in the amygdala and decreased in the PFC. Moreover, the glutamate-related abnormalities in the amygdala and PFC were normalized by single-dose (10 mg/kg, i.p.) ketamine treatment. In contrast, the depressive-like behaviors were not reversed by 28 days of fluoxetine treatment (10 mg/kg, i.p.) in the severe stress group. Our data demonstrated that high levels of traumatic stress could lead to SSRI-resistant depressive symptoms through impacts on the glutamatergic system, and that this rat model has the potential to be a feasible animal model of SSRI-resistant depression.

Original languageEnglish
Pages (from-to)102-113
Number of pages12
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume93
DOIs
Publication statusPublished - Jul 13 2019

Fingerprint

Extracellular Signal-Regulated MAP Kinases
Ketamine
Antidepressive Agents
Serotonin Uptake Inhibitors
Depression
Amygdala
Prefrontal Cortex
Treatment-Resistant Depressive Disorder
Animal Models
Fluoxetine
Shock
Foot
Glutamic Acid
Therapeutics
Public Health
Phosphorylation
Proteins

Keywords

  • Amygdala
  • ERKs
  • Ketamine
  • Prefrontal cortex
  • SSRI-resistant depression
  • Traumatic stress levels

ASJC Scopus subject areas

  • Pharmacology
  • Biological Psychiatry

Cite this

Ketamine ameliorates severe traumatic event-induced antidepressant-resistant depression in a rat model through ERK activation. / Lee, Chi Wei; Chen, Yi Ju; Wu, Han Fang; Chung, Yueh Jung; Lee, Yi Chao; Li, Cheng Ta; Lin, Hui Ching.

In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 93, 13.07.2019, p. 102-113.

Research output: Contribution to journalArticle

@article{94f2739e43b0417e94688863145547c2,
title = "Ketamine ameliorates severe traumatic event-induced antidepressant-resistant depression in a rat model through ERK activation",
abstract = "Treatment-resistant depression (TRD) is a major public health issue, as it is common for patients with depression to fail to respond to adequate trials of antidepressants. However, a well-established animal model of TRD is still warranted. The present study focused on selective serotonin reuptake inhibitor (SSRI) resistance, and aimed to investigate whether higher levels of traumatic stress caused by greater numbers of foot-shocks may lead to severe depression and to examine the feasibility of this as an animal model of SSRI-resistant depression. To reveal the correlation between traumatic stress and severe depression, rats received 3, 6 and 10 tone (conditioned stimulus, CS)–shock (unconditioned stimulus, US) pairings to mimic mild, moderate, and severe traumatic events, and subsequent depressive-like behaviors and protein immunocontents were analyzed. The antidepressant efficacy was assessed for ketamine and SSRI (i.e., fluoxetine) treatment. We found that only the severe stress group presented depressive-like behaviors. Phosphorylation of extracellular signal-regulated kinases (ERKs) was decreased in the amygdala and prefrontal cortex (PFC). The immunocontents of GluA1 and PSD 95 were increased in the amygdala and decreased in the PFC. Moreover, the glutamate-related abnormalities in the amygdala and PFC were normalized by single-dose (10 mg/kg, i.p.) ketamine treatment. In contrast, the depressive-like behaviors were not reversed by 28 days of fluoxetine treatment (10 mg/kg, i.p.) in the severe stress group. Our data demonstrated that high levels of traumatic stress could lead to SSRI-resistant depressive symptoms through impacts on the glutamatergic system, and that this rat model has the potential to be a feasible animal model of SSRI-resistant depression.",
keywords = "Amygdala, ERKs, Ketamine, Prefrontal cortex, SSRI-resistant depression, Traumatic stress levels",
author = "Lee, {Chi Wei} and Chen, {Yi Ju} and Wu, {Han Fang} and Chung, {Yueh Jung} and Lee, {Yi Chao} and Li, {Cheng Ta} and Lin, {Hui Ching}",
year = "2019",
month = "7",
day = "13",
doi = "10.1016/j.pnpbp.2019.03.015",
language = "English",
volume = "93",
pages = "102--113",
journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",
issn = "0278-5846",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Ketamine ameliorates severe traumatic event-induced antidepressant-resistant depression in a rat model through ERK activation

AU - Lee, Chi Wei

AU - Chen, Yi Ju

AU - Wu, Han Fang

AU - Chung, Yueh Jung

AU - Lee, Yi Chao

AU - Li, Cheng Ta

AU - Lin, Hui Ching

PY - 2019/7/13

Y1 - 2019/7/13

N2 - Treatment-resistant depression (TRD) is a major public health issue, as it is common for patients with depression to fail to respond to adequate trials of antidepressants. However, a well-established animal model of TRD is still warranted. The present study focused on selective serotonin reuptake inhibitor (SSRI) resistance, and aimed to investigate whether higher levels of traumatic stress caused by greater numbers of foot-shocks may lead to severe depression and to examine the feasibility of this as an animal model of SSRI-resistant depression. To reveal the correlation between traumatic stress and severe depression, rats received 3, 6 and 10 tone (conditioned stimulus, CS)–shock (unconditioned stimulus, US) pairings to mimic mild, moderate, and severe traumatic events, and subsequent depressive-like behaviors and protein immunocontents were analyzed. The antidepressant efficacy was assessed for ketamine and SSRI (i.e., fluoxetine) treatment. We found that only the severe stress group presented depressive-like behaviors. Phosphorylation of extracellular signal-regulated kinases (ERKs) was decreased in the amygdala and prefrontal cortex (PFC). The immunocontents of GluA1 and PSD 95 were increased in the amygdala and decreased in the PFC. Moreover, the glutamate-related abnormalities in the amygdala and PFC were normalized by single-dose (10 mg/kg, i.p.) ketamine treatment. In contrast, the depressive-like behaviors were not reversed by 28 days of fluoxetine treatment (10 mg/kg, i.p.) in the severe stress group. Our data demonstrated that high levels of traumatic stress could lead to SSRI-resistant depressive symptoms through impacts on the glutamatergic system, and that this rat model has the potential to be a feasible animal model of SSRI-resistant depression.

AB - Treatment-resistant depression (TRD) is a major public health issue, as it is common for patients with depression to fail to respond to adequate trials of antidepressants. However, a well-established animal model of TRD is still warranted. The present study focused on selective serotonin reuptake inhibitor (SSRI) resistance, and aimed to investigate whether higher levels of traumatic stress caused by greater numbers of foot-shocks may lead to severe depression and to examine the feasibility of this as an animal model of SSRI-resistant depression. To reveal the correlation between traumatic stress and severe depression, rats received 3, 6 and 10 tone (conditioned stimulus, CS)–shock (unconditioned stimulus, US) pairings to mimic mild, moderate, and severe traumatic events, and subsequent depressive-like behaviors and protein immunocontents were analyzed. The antidepressant efficacy was assessed for ketamine and SSRI (i.e., fluoxetine) treatment. We found that only the severe stress group presented depressive-like behaviors. Phosphorylation of extracellular signal-regulated kinases (ERKs) was decreased in the amygdala and prefrontal cortex (PFC). The immunocontents of GluA1 and PSD 95 were increased in the amygdala and decreased in the PFC. Moreover, the glutamate-related abnormalities in the amygdala and PFC were normalized by single-dose (10 mg/kg, i.p.) ketamine treatment. In contrast, the depressive-like behaviors were not reversed by 28 days of fluoxetine treatment (10 mg/kg, i.p.) in the severe stress group. Our data demonstrated that high levels of traumatic stress could lead to SSRI-resistant depressive symptoms through impacts on the glutamatergic system, and that this rat model has the potential to be a feasible animal model of SSRI-resistant depression.

KW - Amygdala

KW - ERKs

KW - Ketamine

KW - Prefrontal cortex

KW - SSRI-resistant depression

KW - Traumatic stress levels

UR - http://www.scopus.com/inward/record.url?scp=85063726115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063726115&partnerID=8YFLogxK

U2 - 10.1016/j.pnpbp.2019.03.015

DO - 10.1016/j.pnpbp.2019.03.015

M3 - Article

C2 - 30940482

AN - SCOPUS:85063726115

VL - 93

SP - 102

EP - 113

JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry

SN - 0278-5846

ER -